[go: up one dir, main page]

GB201808150D0 - Therapeutic compounds - Google Patents

Therapeutic compounds

Info

Publication number
GB201808150D0
GB201808150D0 GBGB1808150.5A GB201808150A GB201808150D0 GB 201808150 D0 GB201808150 D0 GB 201808150D0 GB 201808150 A GB201808150 A GB 201808150A GB 201808150 D0 GB201808150 D0 GB 201808150D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic compounds
therapeutic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1808150.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Small Pharma Ltd
Original Assignee
Small Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Small Pharma Ltd filed Critical Small Pharma Ltd
Priority to GBGB1808150.5A priority Critical patent/GB201808150D0/en
Publication of GB201808150D0 publication Critical patent/GB201808150D0/en
Priority to CA3076103A priority patent/CA3076103A1/en
Priority to PCT/GB2018/052726 priority patent/WO2019058145A1/en
Priority to EP18782135.0A priority patent/EP3687515B1/en
Priority to ES18782135T priority patent/ES2924188T3/en
Priority to US16/650,588 priority patent/US20210315840A1/en
Priority to PCT/GB2019/051373 priority patent/WO2019220139A1/en
Priority to PCT/GB2019/051372 priority patent/WO2019220138A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB1808150.5A 2017-09-25 2018-05-18 Therapeutic compounds Ceased GB201808150D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB1808150.5A GB201808150D0 (en) 2018-05-18 2018-05-18 Therapeutic compounds
CA3076103A CA3076103A1 (en) 2017-09-25 2018-09-25 Solid oral dosage forms of ketamine derivatives
PCT/GB2018/052726 WO2019058145A1 (en) 2017-09-25 2018-09-25 Solid oral dosage forms of ketamine derivatives
EP18782135.0A EP3687515B1 (en) 2017-09-25 2018-09-25 Solid oral dosage forms of ketamine derivatives
ES18782135T ES2924188T3 (en) 2017-09-25 2018-09-25 Solid oral dosage forms of ketamine derivatives
US16/650,588 US20210315840A1 (en) 2017-09-25 2018-09-25 Solid oral dosage forms of ketamine derivatives
PCT/GB2019/051373 WO2019220139A1 (en) 2018-05-18 2019-05-17 Ketamine derivatives to treat neurological or psychological disorders
PCT/GB2019/051372 WO2019220138A1 (en) 2018-05-18 2019-05-17 Ketamine derivatives to treat neurological or psychological diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1808150.5A GB201808150D0 (en) 2018-05-18 2018-05-18 Therapeutic compounds

Publications (1)

Publication Number Publication Date
GB201808150D0 true GB201808150D0 (en) 2018-07-11

Family

ID=62812455

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1808150.5A Ceased GB201808150D0 (en) 2017-09-25 2018-05-18 Therapeutic compounds

Country Status (2)

Country Link
GB (1) GB201808150D0 (en)
WO (2) WO2019220138A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3165903A1 (en) 2019-12-26 2021-07-01 Gilgamesh Pharmaceuticals, Inc. Arylcyclohexylamine derivatives and their use in the treatment of psychiatric disorders
PL4084791T3 (en) 2020-02-18 2025-04-22 Gilgamesh Pharmaceuticals, Inc. Specific tryptamines for use in the treatment of mood disorders
US12129234B1 (en) 2023-08-03 2024-10-29 Gilgamesh Pharmaceuticals, Inc. Crystalline salts of N-ethyl-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine
US12157722B1 (en) 2023-08-03 2024-12-03 Gilgamesh Pharmaceuticals, Inc. Crystalline hydrochloride salts of N-ethyl-2-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013056229A1 (en) 2011-10-14 2013-04-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services The use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic pain
EP3485882A1 (en) * 2013-01-25 2019-05-22 Case Western Reserve University Compositions for the treatment of pervasive development disorders
US11110070B2 (en) * 2015-11-17 2021-09-07 The Trustees Of Columbia University In The City Of New York Pharmacological prophylactics against stress-induced affective disorders and their associated symptoms
US11111210B2 (en) * 2015-11-18 2021-09-07 Spirify Pharma Inc. Phenyl cyclohexanone derivatives and methods of making and using them
US20190256487A1 (en) * 2016-09-16 2019-08-22 BioPharmaWorks, LLC Hydroxynorketamine prodrugs
WO2018079693A1 (en) * 2016-10-27 2018-05-03 国立大学法人 千葉大学 Pharmaceutical applications for (s)-norketamine and salts thereof
CA3045148A1 (en) * 2016-11-30 2018-06-07 Philip E. Wolfson Ketamine for the treatment of menstrually related symptoms
US20210315840A1 (en) 2017-09-25 2021-10-14 Small Pharma Ltd Solid oral dosage forms of ketamine derivatives

Also Published As

Publication number Publication date
WO2019220139A1 (en) 2019-11-21
WO2019220138A1 (en) 2019-11-21

Similar Documents

Publication Publication Date Title
SG11202104461XA (en) Therapeutic methods
GB201820166D0 (en) Therapeutic agents
GB201820165D0 (en) Therapeutic agents
GB201804255D0 (en) Macrophage-based therapy
SG11202103253YA (en) Therapeutic compounds
GB201616839D0 (en) Therapeutic compounds
GB201716942D0 (en) Therapeutic compounds
GB201601703D0 (en) Therapeutic compounds
GB201819853D0 (en) Therapy
GB201805816D0 (en) Therapeutic agents
GB201808150D0 (en) Therapeutic compounds
GB201617339D0 (en) Therapeutic compounds
GB201908885D0 (en) Therapeutic compounds
IL263821A (en) Therapeutic compounds
GB201817385D0 (en) Therapy
GB201818579D0 (en) New therapy
GB201814036D0 (en) New therapy
GB201712884D0 (en) Novel therapeutic compounds
GB201911574D0 (en) Therapeutic compounds
GB201911580D0 (en) Therapeutic compounds
GB201907813D0 (en) Therapeutic compounds
GB201903597D0 (en) Therapeutic compounds
GB201903599D0 (en) Therapeutic compounds
GB201820895D0 (en) Therapy
GB201807147D0 (en) Therapeutic combination

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)